234 related articles for article (PubMed ID: 32132648)
1. Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus.
Garg H; Mehmetoglu-Gurbuz T; Joshi A
Sci Rep; 2020 Mar; 10(1):4017. PubMed ID: 32132648
[TBL] [Abstract][Full Text] [Related]
2. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
Garg H; Sedano M; Plata G; Punke EB; Joshi A
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
[TBL] [Abstract][Full Text] [Related]
3. Capsid containing virus like particle vaccine against Zika virus made from a stable cell line.
Garg H; Mehmetoglu-Gurbuz T; Ruddy GM; Joshi A
Vaccine; 2019 Nov; 37(48):7123-7131. PubMed ID: 31607605
[TBL] [Abstract][Full Text] [Related]
4. Zika virus-like particle (VLP) based vaccine.
Boigard H; Alimova A; Martin GR; Katz A; Gottlieb P; Galarza JM
PLoS Negl Trop Dis; 2017 May; 11(5):e0005608. PubMed ID: 28481898
[TBL] [Abstract][Full Text] [Related]
5. A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.
Kum DB; Boudewijns R; Ma J; Mishra N; Schols D; Neyts J; Dallmeier K
Emerg Microbes Infect; 2020; 9(1):520-533. PubMed ID: 32116148
[TBL] [Abstract][Full Text] [Related]
6. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
[TBL] [Abstract][Full Text] [Related]
7. Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus.
Vang L; Morello CS; Mendy J; Thompson D; Manayani D; Guenther B; Julander J; Sanford D; Jain A; Patel A; Shabram P; Smith J; Alexander J
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009195. PubMed ID: 33711018
[TBL] [Abstract][Full Text] [Related]
8. Yellow fever vaccine protects mice against Zika virus infection.
Vicente Santos AC; Guedes-da-Silva FH; Dumard CH; Ferreira VNS; da Costa IPS; Machado RA; Barros-Aragão FGQ; Neris RLS; Dos-Santos JS; Assunção-Miranda I; Figueiredo CP; Dias AA; Gomes AMO; de Matos Guedes HL; Oliveira AC; Silva JL
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009907. PubMed ID: 34735450
[TBL] [Abstract][Full Text] [Related]
9. Zika virus like particles elicit protective antibodies in mice.
Salvo MA; Kingstad-Bakke B; Salas-Quinchucua C; Camacho E; Osorio JE
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006210. PubMed ID: 29401460
[TBL] [Abstract][Full Text] [Related]
10. Zika virus-like particle vaccine fusion loop mutation increases production yield but fails to protect AG129 mice against Zika virus challenge.
Thompson D; Guenther B; Manayani D; Mendy J; Smith J; Espinosa DA; Harris E; Alexander J; Vang L; Morello CS
PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010588. PubMed ID: 35793354
[TBL] [Abstract][Full Text] [Related]
11. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
[TBL] [Abstract][Full Text] [Related]
12. Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform.
Alvim RGF; Itabaiana I; Castilho LR
Vaccine; 2019 Nov; 37(47):6970-6977. PubMed ID: 31164305
[TBL] [Abstract][Full Text] [Related]
13. A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections.
Chattopadhyay A; Aguilar PV; Bopp NE; Yarovinsky TO; Weaver SC; Rose JK
Vaccine; 2018 Jun; 36(27):3894-3900. PubMed ID: 29807712
[TBL] [Abstract][Full Text] [Related]
14. Purification of flavivirus VLPs by a two-step chomatographic process.
Lima TM; Souza MO; Castilho LR
Vaccine; 2019 Nov; 37(47):7061-7069. PubMed ID: 31201056
[TBL] [Abstract][Full Text] [Related]
15. Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge.
Espinosa D; Mendy J; Manayani D; Vang L; Wang C; Richard T; Guenther B; Aruri J; Avanzini J; Garduno F; Farness P; Gurwith M; Smith J; Harris E; Alexander J
EBioMedicine; 2018 Jan; 27():61-70. PubMed ID: 29269041
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of a new mammalian cell line continuously expressing virus-like particles of Japanese encephalitis virus for a subunit vaccine candidate.
Hua RH; Li YN; Chen ZS; Liu LK; Huo H; Wang XL; Guo LP; Shen N; Wang JF; Bu ZG
BMC Biotechnol; 2014 Jul; 14():62. PubMed ID: 25011456
[TBL] [Abstract][Full Text] [Related]
17. Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine.
Lima NS; Moon D; Darko S; De La Barrera RA; Lin L; Koren MA; Jarman RG; Eckels KH; Thomas SJ; Michael NL; Modjarrad K; Douek DC; Trautmann L
Front Immunol; 2021; 12():640190. PubMed ID: 33717194
[TBL] [Abstract][Full Text] [Related]
18. Genotype I of Japanese Encephalitis Virus Virus-like Particles Elicit Sterilizing Immunity against Genotype I and III Viral Challenge in Swine.
Fan YC; Chen JM; Lin JW; Chen YY; Wu GH; Su KH; Chiou MT; Wu SR; Yin JH; Liao JW; Chang GJ; Chiou SS
Sci Rep; 2018 May; 8(1):7481. PubMed ID: 29748549
[TBL] [Abstract][Full Text] [Related]
19. A Bivalent, Spherical Virus-Like Particle Vaccine Enhances Breadth of Immune Responses against Pathogenic Ebola Viruses in Rhesus Macaques.
Singh K; Marasini B; Chen X; Ding L; Wang JJ; Xiao P; Villinger F; Spearman P
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075939
[TBL] [Abstract][Full Text] [Related]
20. Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine.
Giel-Moloney M; Goncalvez AP; Catalan J; Lecouturier V; Girerd-Chambaz Y; Diaz F; Maldonado-Arocho F; Gomila RC; Bernard MC; Oomen R; Delagrave S; Burdin N; Kleanthous H; Jackson N; Heinrichs J; Pugachev KV
Sci Rep; 2018 Sep; 8(1):13206. PubMed ID: 30181550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
